FBIOP

#7311
Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock
19.4 7 USD
+0.67%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
19.42
19.48
Year Range
6.27
19.48
Daily Change
+0.67%
Monthly Change
+35.21%
6 month change
+180.95%
Year Change
+180.55%
Previous Close
19.3 4
Open
19.4 3
Low
19.4 2
High
19.4 8
Volume
17
Open full chart Full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Income statement Balance sheet Cash flow
Value 202020212022202320242025 TTM

Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock

Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida.

News